Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum ; day:5 ; month:7 ; year:2023 ; pages:1-9
The journal of prevention of Alzheimer's disease ; (5.7.2023), 1-9
- Urheber
-
Feizpour, A.
Doré, V.
Doecke, J. D.
Saad, Z. S.
Triana-Baltzer, G.
Slemmon, R.
Maruff, P.
Krishnadas, N.
Bourgeat, P.
Huang, K.
Fowler, C.
Rainey-Smith, S. R.
Bush, A. I.
Ward, L.
Robertson, J.
Martins, R. N.
Masters, C. L.
Villemagne, V. L.
Fripp, J.
Kolb, H. C.
Rowe, Christopher C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2023.83
- URN
-
urn:nbn:de:101:1-2023101110222551806085
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Feizpour, A.
- Doré, V.
- Doecke, J. D.
- Saad, Z. S.
- Triana-Baltzer, G.
- Slemmon, R.
- Maruff, P.
- Krishnadas, N.
- Bourgeat, P.
- Huang, K.
- Fowler, C.
- Rainey-Smith, S. R.
- Bush, A. I.
- Ward, L.
- Robertson, J.
- Martins, R. N.
- Masters, C. L.
- Villemagne, V. L.
- Fripp, J.
- Kolb, H. C.
- Rowe, Christopher C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Glial activation and inflammation along the Alzheimer’s disease continuum
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Glial activation and inflammation along the Alzheimer’s disease continuum
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
Glial activation and inflammation along the Alzheimer’s disease continuum
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Melatonin levels in the Alzheimer’s disease continuum: a systematic review
On the path to 2025: understanding the Alzheimer’s disease continuum
Memory markers in the continuum of the Alzheimer’s clinical syndrome
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies